Knight Capital Group’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
SM
Knight Capital Group's ORKA Position: Q2 2013 in Review
Knight Capital Group reported 77 shares of Oruka Therapeutics (ORKA) worth $150K in Q2 2013. The position accounts for ﹤0.01% of the portfolio, ranked #2834.
12 funds tracked by Wall St. Rank hold ORKA as of Q2 2013.
- Knight Capital Group held 77 shares of Oruka Therapeutics worth $150K as of Q2 2013.
- Oruka Therapeutics made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2834 holding.
- 12 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2013.
Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.